Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer.

Chang P, Szymanski KM, Dunn RL, Chipman JJ, Litwin MS, Nguyen PL, Sweeney CJ, Cook R, Wagner AA, DeWolf WC, Bubley GJ, Funches R, Aronovitz JA, Wei JT, Sanda MG.

J Urol. 2011 Sep;186(3):865-72. doi: 10.1016/j.juro.2011.04.085. Epub 2011 Jul 23.

2.

A systematic review of expanded prostate cancer index composite (EPIC) quality of life after surgery or radiation treatment.

Lee TK, Breau RH, Mallick R, Eapen L.

Can J Urol. 2015 Feb;22(1):7599-606. Review.

PMID:
25694006
3.
4.

Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index.

Byock IR, Merriman MP.

Palliat Med. 1998 Jul;12(4):231-44. Review.

PMID:
9743822
5.

Measuring health related quality of life in men with prostate cancer.

Litwin MS.

J Urol. 1994 Nov;152(5 Pt 2):1882-7. Review.

PMID:
7933244
6.

Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity.

Hamoen EH, De Rooij M, Witjes JA, Barentsz JO, Rovers MM.

Urol Oncol. 2015 Feb;33(2):69.e19-28. doi: 10.1016/j.urolonc.2013.10.005. Epub 2014 Jan 13. Review.

PMID:
24433753
7.

Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity.

Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fosså SD, Kaasa S.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):793-804. doi: 10.1016/j.ijrobp.2009.05.057. Epub 2009 Oct 29. Review.

PMID:
19879063
8.

Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments.

Rnic K, Linden W, Tudor I, Pullmer R, Vodermaier A.

Prostate Cancer Prostatic Dis. 2013 Jun;16(2):111-22. doi: 10.1038/pcan.2013.1. Epub 2013 Feb 5. Review.

PMID:
23381695
9.

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, Watkins-Bruner D, Reeve BB, Sandler HM.

J Natl Cancer Inst. 2014 Jul 8;106(7). pii: dju132. doi: 10.1093/jnci/dju132. Print 2014 Jul. Review.

10.

Novel approaches in the high-risk prostate cancer patient: Summary of key research presented at AUA 2014.

[No authors listed]

Can Urol Assoc J. 2014 Jul;8(7-8 Suppl 4):S137. doi: 10.5489/cuaj.2285. Review.

Items per page

Supplemental Content

Write to the Help Desk